A. Maguire, K. High, A. Auricchio, J. Wright, . Pierce et al., Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial, The Lancet, vol.374, issue.9701, pp.1597-1605, 2009.
DOI : 10.1016/S0140-6736(09)61836-5

A. Maguire, F. Simonelli, . Pierce, . Ea, . Pugh et al., Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis, New England Journal of Medicine, vol.358, issue.21, pp.2240-2248, 2008.
DOI : 10.1056/NEJMoa0802315

J. Bainbridge, . Smith, . Barker, . Ss, S. Robbie et al., Effect of Gene Therapy on Visual Function in Leber's Congenital Amaurosis, New England Journal of Medicine, vol.358, issue.21, pp.2231-2239, 2008.
DOI : 10.1056/NEJMoa0802268

URL : http://cvrl.ioo.ucl.ac.uk/people/stockman/pubs/2008 gene therapy b et al.pdf

A. Nathwani, . Tuddenham, . Eg, S. Rangarajan, C. Rosales et al., Adenovirus-Associated Virus Vector???Mediated Gene Transfer in Hemophilia B, New England Journal of Medicine, vol.365, issue.25, pp.2357-2365, 2011.
DOI : 10.1056/NEJMoa1108046

URL : http://europepmc.org/articles/pmc3265081?pdf=render

A. Nathwani, . Reiss, . Um, . Tuddenham, . Eg et al., Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B, New England Journal of Medicine, vol.371, issue.21, pp.1994-2004, 2014.
DOI : 10.1056/NEJMoa1407309

R. Maclaren, M. Groppe, A. Barnard, C. Cottriall, T. Tolmachova et al., Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial, The Lancet, vol.383, issue.9923, pp.1129-1137, 2014.
DOI : 10.1016/S0140-6736(13)62117-0

E. Stroes, . Nierman, . Mc, J. Meulenberg, R. Franssen et al., Intramuscular Administration of AAV1-Lipoprotein LipaseS447X Lowers Triglycerides in Lipoprotein Lipase-Deficient Patients, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.28, issue.12, pp.2303-2304, 2008.
DOI : 10.1161/ATVBAHA.108.175620

URL : http://atvb.ahajournals.org/content/atvbaha/28/12/2303.full.pdf

A. Carpentier, F. Frisch, . Labbé, . Sm, R. Gagnon et al., ) on Postprandial Chylomicron Metabolism in Lipoprotein Lipase-Deficient Patients, The Journal of Clinical Endocrinology & Metabolism, vol.97, issue.5, pp.1635-1644, 2012.
DOI : 10.1210/jc.2011-3002

URL : https://academic.oup.com/jcem/article-pdf/97/5/1635/7925516/jcem1635.pdf

J. Grieger, . Soltys, . Sm, and R. Samulski, Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector, Molecular Therapy, vol.24, issue.2, 2015.
DOI : 10.1038/mt.2015.187

A. Srivastava, . Lusby, and K. Berns, Nucleotide sequence and organization of the adeno-associated virus 2 genome, J Virol, vol.45, pp.555-564, 1983.

F. Sonntag, K. Köther, K. Schmidt, M. Weghofer, C. Raupp et al., The Assembly-Activating Protein Promotes Capsid Assembly of Different Adeno-Associated Virus Serotypes, Journal of Virology, vol.85, issue.23, pp.12686-12697, 2011.
DOI : 10.1128/JVI.05359-11

URL : http://jvi.asm.org/content/85/23/12686.full.pdf

P. Hermonat and N. Muzyczka, Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells., Proceedings of the National Academy of Sciences, vol.81, issue.20, pp.6466-6470, 1984.
DOI : 10.1073/pnas.81.20.6466

URL : http://www.pnas.org/content/81/20/6466.full.pdf

X. Xiao, . Li, and R. Samulski, Production of high-titer recombinant adenoassociated virus vectors in the absence of helper adenovirus, J Virol, vol.72, pp.2224-2232, 1998.

J. Wright, . Wellman, and K. High, Manufacturing and Regulatory Strategies for Clinical AAV2-hRPE65, Current Gene Therapy, vol.10, issue.5, pp.341-349, 2010.
DOI : 10.2174/156652310793180715